Cargando…
Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke
Stroke is the leading cause of serious long-term disability, significantly reducing mobility in almost half of the affected patients aged 65 years and older. There are currently no proven neurorestorative treatments for chronic stroke. To address the complex problem of restoring function in ischemic...
Autores principales: | He, Joy Q., Sussman, Eric S., Steinberg, Gary K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767918/ https://www.ncbi.nlm.nih.gov/pubmed/33381020 http://dx.doi.org/10.3389/fnagi.2020.575990 |
Ejemplares similares
-
Corrigendum: Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke
por: He, Joy Q., et al.
Publicado: (2022) -
Hemorrhagic Transformation: A Review of the Rate of Hemorrhage in the Major Clinical Trials of Acute Ischemic Stroke
por: Sussman, Eric S., et al.
Publicado: (2013) -
Potential of Stem Cell-Based Therapy for Ischemic Stroke
por: Marei, Hany E., et al.
Publicado: (2018) -
Induced Pluripotent Stem Cells for Ischemic Stroke Treatment
por: Duan, Ranran, et al.
Publicado: (2021) -
Insight Into the Mechanisms and the Challenges on Stem Cell-Based Therapies for Cerebral Ischemic Stroke
por: Liu, Huiyong, et al.
Publicado: (2021)